U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 251 - 260 of 995

Substance Use Confidentiality Regulations

General FAQs about substance abuse confidentiality regulations

Format
Web Page
Audience
Other Team Members
Policymakers and Payers
States
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

SUD 101 Core Curriculum

The modules in the curriculum provide an overview of evidence-based practices in the prevention, identification, and treatment of substance use disorders and co-occurring medical and psychiatric conditions for a variety of populations.

Format
Curriculum
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Source
Providers Clinical Support System (PCSS)
Year
Resource Type
Web Page

Suggesting Treatment to a Loved One

This fact sheet includes several tips for suggesting that a loved one receive treatment for substance use.
Format
Fact Sheet/Brochure
Audience
Families
Communities
Schools
Source
Partnership to End Addiction
Year
Resource Type
Web Page

The Clinical Practice Guideline on the Management of Stimulant Use Disorder (PDF - 1.9 MB KB)

This guideline provide evidence-based strategies and standards of care for the treatment of stimulant use disorders, stimulant intoxication, and stimulant withdrawal, as well as secondary and tertiary prevention of harms associated with stimulant use.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM) / American Academy of Addiction Psychiatry (AAAP)
Year
Resource Type
PDF

The Role of Low-Threshold Treatment for Patients with Opioid Use Dusirder (OUD) in Primary Care

This Topic Brief provides an overview of what constitutes low-threshold treatment for patients with OUD, the state of the evidence and patient perspectives on low-threshold OUD treatment, and key steps and strategies for providing low-threshold treatment for patients with OUD in primary care settings.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Agency of Healthcare Quality and Research (AHRQ) Integration Academy
Year
Resource Type
Web Page

Updated DEA Registration Certificate after Removal of X-Waiver (PDF - 92.4 KB KB)

This guidance document provides information regarding issuance of updated DEA registration certificates to reflect Congress’s elimination of the X-waiver (DATA-Waiver) in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF

Variation Across States in Loss of Medicaid Coverage Among Pregnant Beneficiaries with Substance Use Disorders (PDF - 657 KB KB)

Using a national Medicaid claims database, this brief estimates the number of pregnant beneficiaries with substance use disorder who lost Medicaid coverage 60 days postpartum at the national and state-level.
Format
Report/Paper/Issue Brief
Audience
States
Policymakers and Payers
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Assistant Secretary for Planning and Evaluation (ASPE)
Year
Resource Type
PDF

Waiver Elimination (MAT Act)

This web page provides frequently asked questions regarding the 2023 Consolidated Appropriations Act, which eliminates the X-waiver (DATA-Waiver) and increases accessibility of medication-assisted treatment (MAT).
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page